NFL Biosciences SA Financial Overview
NFL Biosciences SA's market cap is currently €14.76M. The company's EPS TTM is €-0.142; its P/E ratio is -3.83; NFL Biosciences SA is scheduled to report earnings on October 16, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
